Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

New Frontiers on Hyperlipidemia in Pharmaceutical Education


Affiliations
1 Bharat Technology, Banitabla, Uluberia, Howrah, W.B., India
     

   Subscribe/Renew Journal


The condition of hyperlipidemia can be described as high cholesterol in the blood (hypercholesterolemia), high triglycerides in the blood (hypertriglyceridemia) or it could be both. Hyperlipidemia is a major risk factor in the initiation and progression of atherosclerotic lesions, conditions such as coronary heart disease, ischemic cerebrovascular disease and peripheral vascular disease which leads high morbidity rate in developed countries. The present article gives different classes of anti-hyperlipidemics highlighting the pathophysiology of artherosclerosis, classification, side effects and therapeutic uses of antihyperlipidemics.

Keywords

Hyperlipidemia, Cholesterol, Atherosclerotic Blood Vessel.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Devlin, T. (1995): Textbook of biochemistry with clinical correlations, New York, Wiley - Liss Inc, 3rd edition, pp. 376-381.

  • Yan Feng, Xiumei Hong, Elissa Wilker, Zhiping Li, Wenbin Zhang, Delai Jin, Xue Liu, Tonghua Zang, Xiping Xu, and Xin Xu; Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases; Atherosclerosis. Feb 2008; 196(2) pp 590-597.

  • Claudio Rigatto, Patrick Parfrey; Factors Governing Cardiovascular Risk In The Patient With A Failing Renal Transplant; Peritoneal Dialysis International, June 2001; Vol. 21 (3), pp 275.

  • Olin B.R, Hebel S.K, Dombek C.E, Drug Facts and Comparisons. 2007 edition. pp-57.

  • Simon C, Everitt H, Kendrick T. Oxford Handbook of General Practice. 2nd edn. Oxford: Oxford University Press, 2007: pp-324-325.

  • Axel K. Duwe; Depressed Natural Killer and Lecithin-Induced Cell-Mediated Cytotoxicity in Cholesterol-Fed Guinea Pigs; journal of the national cancer institute; 1984; 72(2): pp-333-338.

  • Peter Libby; Review article Inflammation in atherosclerosis; Nature, December 2002; 420, pp-868-874.

  • Kumar A & Sharma A Kumar; Ayurvedic Management Of High Cholesterol; Ayurveda; December, 2009; 1(15); pp-23-26.

  • Allain, C.C., Poon, L.S. and Chen, C.S. Enzymatic determination of total serum cholesterol, Clin Chem, 1974: 20, pp. 470-475.

  • Murty, M.K.M. Surulivel. and Manavalan, R. (2006): "The effect of hippophae rhamnoidis L fruit juice and rhododendron arboreum flower juice mixture in rabbit model of hyperlipidaemia", pp. 1.

  • Tripathi, K.D. (2003): Essentials of medical pharmacology, Jaypee brothers medical publishers (P) LTD, New Delhi, 5th edn., pp. 575.

  • Inoue, M., Wu, C.Z. and Ogihara, Y. (1999): "Antihyperlipidemic action of Ogi-Keishi-Gomotsu-To-Ka-Kojin against cyclophosphamide-induced hyperlipidemia in rabbits", Biol Pharm Bull, pp. 486.

  • Inoue, M. (2000): Shosaikoto "as a potential antiatherosclerotic agent", Drug News Perspect. pp. 407.

  • Johnston, T.P. (2004): "The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis", J Cardiovasc Pharmacol, pp. 595.


Abstract Views: 269

PDF Views: 2




  • New Frontiers on Hyperlipidemia in Pharmaceutical Education

Abstract Views: 269  |  PDF Views: 2

Authors

L. K. Kanthal
Bharat Technology, Banitabla, Uluberia, Howrah, W.B., India
P. Mondal
Bharat Technology, Banitabla, Uluberia, Howrah, W.B., India
D. Saha
Bharat Technology, Banitabla, Uluberia, Howrah, W.B., India
D. Mridha
Bharat Technology, Banitabla, Uluberia, Howrah, W.B., India
S. Mandal
Bharat Technology, Banitabla, Uluberia, Howrah, W.B., India

Abstract


The condition of hyperlipidemia can be described as high cholesterol in the blood (hypercholesterolemia), high triglycerides in the blood (hypertriglyceridemia) or it could be both. Hyperlipidemia is a major risk factor in the initiation and progression of atherosclerotic lesions, conditions such as coronary heart disease, ischemic cerebrovascular disease and peripheral vascular disease which leads high morbidity rate in developed countries. The present article gives different classes of anti-hyperlipidemics highlighting the pathophysiology of artherosclerosis, classification, side effects and therapeutic uses of antihyperlipidemics.

Keywords


Hyperlipidemia, Cholesterol, Atherosclerotic Blood Vessel.

References